Clinical trial
Apixaban to Prevent dEcompensation of eArly Liver CirrHosis Trial
NCT07726693 is registered in ClinicalTrials.gov with University College, London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Apixaban to Prevent dEcompensation of eArly Liver CirrHosis Trial
- Lead sponsor
- University College, London
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- July 15, 2026
- Completion date
- March 30, 2031
- Enrollment
- 1,142 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.